Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$98,333 | -$66,394 | -$59,277 | -$50,622 |
| Dep. & Amort. | $2,002 | $1,843 | $1,145 | $13 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12,474 | $3,043 | $1,781 | $386 |
| Change in WC | $2,729 | $1,482 | $1,791 | $6,041 |
| Other Non-Cash | -$23 | $530 | $0 | $0 |
| Operating Cash Flow | -$81,151 | -$59,496 | -$54,560 | -$44,182 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$481 | -$115 | -$672 | -$188 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$93,596 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$50 | -$229 | $0 |
| Investing Cash Flow | -$94,077 | -$165 | -$901 | -$188 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$410 | $3,575 | -$163 | $0 |
| Stock Issued | $88,712 | $100,251 | $0 | $0 |
| Stock Repurch. | -$17 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $491 | -$35 | $332 | -$203 |
| Financing Cash Flow | $88,776 | $103,791 | $189 | $150,857 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$86,452 | $44,130 | -$55,272 | $106,487 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $124,718 | $80,588 | $135,860 | $29,373 |
| End Cash | $38,266 | $124,718 | $80,588 | $135,860 |
| Free Cash Flow | -$81,632 | -$59,661 | -$55,461 | -$44,370 |